Skip to content

Author

K. Miyamoto

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Guideline-directed medical therapy and outcomes across cardiac and noncardiac domains in systolic heart failure

Guideline-directed medical therapy (GDMT) for heart failure (HF) reduces major adverse cardiovascular events (MACE), including cardiac death and HF hospitalization. However, whether comorbidities influence GDMT effectiveness and dose optimization remains unclear. To determine whether the association betwee...

S. Higuchi, Y. Shiraishi, T. Kohno et al. · 0 citations
Nov 2026

Abstract 15728: Clinical and Hemodynamic Phenotypes of Residual Pulmonary Hypertension After Acute Decompensated Heart Failure Hospitalization

Introduction: Residual pulmonary hypertension (PH) after stabilization from acute decompensated heart failure (ADHF) is common and reflects heterogeneous pathophysiological mechanisms, involving left-sided filling pressures, pulmonary vascular remodeling, right-sided dysfunction, and comorbidity burden. Such heterog...

T. Iwanaga, Y. Shiraishi, S. Kohsaka et al. · 0 citations
Open access Oct 2026

Association of residual pulmonary hypertension with sudden cardiac death after hospitalisation for acute decompensated heart failure

Sudden cardiac death (SCD) remains a major cause of mortality in patients with heart failure (HF) despite advances in medical and device therapy. Risk stratification relies largely on left ventricular ejection fraction (LVEF), yet many SCD events occur outside conventional implantable cardioverter-defibrillator (...

T. Tamura, Y. Shiraishi, S. Kosaka et al. · 0 citations
Oct 2026

Guideline-directed medical therapy implementation and its association with cardiac adverse events across cardiac and noncardiac risk domains.

BACKGROUND Guideline-directed medical therapy (GDMT) improves prognosis in heart failure (HF), but its implementation remains suboptimal, particularly in patients with multiple risk domains. METHODS We analyzed the association between GDMT achievement and the 2-year composite endpoint of cardiac death or HF hospitali...

S. Higuchi, Y. Shiraishi, Takashi Kohno et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.